Skip to main content

Table 1 Demographics of TA-TAVI hospital-acquired infections

From: Surgical site infections following transcatheter apical aortic valve implantation: incidence and management

Patient Sex Age LV% KG/BMI Co-morbidity ES Complications
1. AB F 79 65 66/33 TIA 23 Pneumothorax
      Hypothyroidism   UTI
      Previous CABG   CK-MB: 32.4
      Cr cl: 31.0   
2. JGC M 79 50 78/27 AF/COPD 26 AF, renal failure,
      PVD   heart failure, pneumonia, empyema CK-MB: 33.4
      Gout   
      RA/steroids   
      History DVT Previous CABG   
      Cr cl: 31.8   
3. IR F 76 65 72/30 Hypothyroidism 23 AF/Flutter
      Previous DVT/PE   CK-MB: 18.8
      Porcelain aorta   
      Cr cl: 61.8   
4.MB F 64 50 92.5/35.2 DM/MI 26 Heart failure
      Pulmonary emboli   CK-MB: 12.4
      Lung Ca/Rorx   
      Cr cl: 69.4   
5. CR F 77 20 82/31.2 PAF/PVD 26 Heart failure
      Hypothyroidism   CK-MB : 12.4
      Active smoker   
      COPD   
      Heart failure   
      Cr cl: 26.5   
  1. AF Atrial fibrillation, CA cancer; CABG; Coronary artery bypass grafting; Cr cl, Creatinine (clearance ml/min); COPD Chronic obstructive pulmonary disease; DVT Deep venous thrombosis; DM Diabetes mellitus; MI Myocardial infarction; PAF, Paroxysmal AF; PE Pulmonary emboli; RA Rheumatoid arthritis; RoRX radiotherapy.